Susan Ramos-Hunter

Title: Susan Ramos-Hunter: Innovator in RNAi Therapeutics

Introduction

Susan Ramos-Hunter is a prominent inventor based in Hendersonville, TN (US). She has made significant contributions to the field of RNA interference (RNAi) therapeutics, particularly in the context of treating skeletal muscle-related diseases.

Latest Patents

Susan holds a patent for "RNAi agents for inhibiting expression of DUX4, compositions thereof, and methods of use." This patent describes RNAi agents and compositions that include these agents, aimed at inhibiting the expression of the double homeobox 4 (DUX4) gene. The DUX4 RNAi agents and their conjugates are designed to effectively inhibit DUX4 gene expression, which can provide therapeutic benefits for individuals suffering from conditions such as Facioscapulohumeral Muscular Dystrophy (FSHD).

Career Highlights

Susan is currently associated with Arrowhead Pharmaceuticals, Inc., where she continues to advance her research in RNAi technologies. Her work focuses on developing pharmaceutical compositions that incorporate DUX4 RNAi agents, potentially in combination with other therapeutics, to enhance treatment efficacy.

Collaborations

Some of her notable coworkers include Zhi-Ming Ding and Jonathan Van Dyke, who collaborate with her in the pursuit of innovative solutions in RNAi therapeutics.

Conclusion

Susan Ramos-Hunter's contributions to RNAi therapeutics represent a significant advancement in the treatment of skeletal muscle-related disorders. Her innovative work continues to pave the way for new therapeutic strategies that can improve patient outcomes.